Clinical Trial Update: A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 study evaluating C-CAR039 in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• C-CAR039

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: B-cell Non-Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED